FindTrial
Sign In

Effect of healthy habits on cardiovascular risk factors in patients with Ischemic Stroke or Transient Ischemic Attack

Effect of healthy habits on cardiovascular risk factors in patients with Ischemic Stroke or TIA: a randomized study according to AHA Life’s Essential 8 health indicators

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9kv6mqc
Enrollment
Unknown
Registered
2025-07-11
Start date
2025-03-19
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

This is an open-label, randomized, controlled clinical trial with blinded outcome assessment, in which participants will be allocated by simple randomization into two groups: intervention and control.
F01.829.458.205

Sponsors

Hospital de Clínicas da Universidade Federal do Paraná
Lead Sponsor
Hospital de Clínicas da Universidade Federal do Paraná
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients diagnosed with Ischemic Stroke or Transient Ischemic Attack (TIA) within the past 48 hours, with a modified Rankin score less than 2; aged 18 years or older; of both sexes; and with a signed informed consent form

Exclusion criteria

Exclusion criteria: Patients with severe chronic diseases that may interfere with the study (e.g., active cancer, advanced renal failure); severe psychiatric disorders; and/or inability to participate in educational and follow-up sessions

Design outcomes

Primary

MeasureTime frame
Biological Markers (Fasting Blood Glucose, Non-HDL Cholesterol, Blood Pressure and Body Mass Index)—

Secondary

MeasureTime frame
Occurrence of major cardiovascular events (myocardial infarction, recurrent stroke, cardiovascular death) during the 90 days of follow-up.—

Countries

Brazil

Contacts

Public ContactMarcos Lange

Hospital de Clínicas da Universidade Federal do Paraná

langeneuro@gmail.com+ 55 (41) 3360-1800

Outcome results

None listed

Source: REBEC (via WHO ICTRP)